COALAS NATURPRODUKTER ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/4
Bankruptcy risk for industry  3.5% 3.5% 3.5% 3.5% 3.5%  
Bankruptcy risk  1.5% 1.8% 2.1% 2.6% 3.7%  
Credit score (0-100)  76 70 67 60 52  
Credit rating  A A A BBB BBB  
Credit limit (kDKK)  15.5 2.2 0.3 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/4

Net sales  0 0 0 0 0  
Gross profit  2,472 2,079 1,929 1,515 568  
EBITDA  907 482 392 245 23.7  
EBIT  778 353 140 77.3 -74.3  
Pre-tax profit (PTP)  736.6 304.9 104.1 58.2 -74.6  
Net earnings  573.9 236.5 81.2 45.4 -58.2  
Pre-tax profit without non-rec. items  737 305 104 58.2 -74.6  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/4

Tangible assets total  528 1,500 1,797 1,629 1,531  
Shareholders equity total  2,098 3,192 3,274 3,319 3,261  
Interest-bearing liabilities  1,176 1,297 1,089 1,040 0.0  
Balance sheet total (assets)  7,222 8,232 7,823 7,645 6,499  

Net Debt  -1,661 -482 -397 -1,290 -1,346  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/4

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,472 2,079 1,929 1,515 568  
Gross profit growth  14.1% -15.9% -7.2% -21.5% -62.5%  
Employees  5 5 5 4 4  
Employee growth %  0.0% 0.0% 0.0% -20.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  7,222 8,232 7,823 7,645 6,499  
Balance sheet change%  14.1% 14.0% -5.0% -2.3% -15.0%  
Added value  906.6 481.7 392.3 329.4 23.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -256 -14 989 -353 -236  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  5.0 5.0 5.0 5.0 -1.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/4
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  31.5% 17.0% 7.3% 5.1% -13.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  11.5% 4.6% 1.7% 1.0% -1.0%  
ROI %  25.4% 8.7% 3.0% 1.7% -1.8%  
ROE %  31.7% 8.9% 2.5% 1.4% -1.8%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/4
Equity ratio %  29.1% 38.8% 41.8% 43.4% 50.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -183.3% -100.1% -101.2% -525.8% -5,674.8%  
Gearing %  56.0% 40.6% 33.3% 31.3% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  3.5% 3.9% 3.0% 1.9% 0.6%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/4
Quick Ratio  1.0 0.9 1.0 1.1 1.2  
Current Ratio  1.3 1.4 1.4 1.5 1.7  
Cash and cash equivalent  2,837.1 1,779.1 1,486.3 2,329.9 1,346.3  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/4
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,620.4 1,973.4 1,741.6 1,950.1 1,998.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/4
Net sales / employee  0 0 0 0 0  
Added value / employee  181 96 78 82 6  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  181 96 78 61 6  
EBIT / employee  156 71 28 19 -19  
Net earnings / employee  115 47 16 11 -15